- Home
- PCVX vs COTY Comparison
PCVX vs COTY Comparison
Compare PCVX & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- COTY
- Stock Information
- Founded
- PCVX 2013
- COTY 1904
- Country
- PCVX United States
- COTY United States
- Employees
- PCVX N/A
- COTY N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- COTY Package Goods/Cosmetics
- Sector
- PCVX Health Care
- COTY Consumer Discretionary
- Exchange
- PCVX Nasdaq
- COTY Nasdaq
- Market Cap
- PCVX 4.0B
- COTY 3.5B
- IPO Year
- PCVX 2020
- COTY 2013
- Fundamental
- Price
- PCVX $31.00
- COTY $4.16
- Analyst Decision
- PCVX Strong Buy
- COTY Hold
- Analyst Count
- PCVX 8
- COTY 17
- Target Price
- PCVX $114.17
- COTY $5.77
- AVG Volume (30 Days)
- PCVX 1.4M
- COTY 13.3M
- Earning Date
- PCVX 11-04-2025
- COTY 11-05-2025
- Dividend Yield
- PCVX N/A
- COTY N/A
- EPS Growth
- PCVX N/A
- COTY N/A
- EPS
- PCVX N/A
- COTY N/A
- Revenue
- PCVX N/A
- COTY $5,892,900,000.00
- Revenue This Year
- PCVX N/A
- COTY $2.43
- Revenue Next Year
- PCVX N/A
- COTY $3.66
- P/E Ratio
- PCVX N/A
- COTY N/A
- Revenue Growth
- PCVX N/A
- COTY N/A
- 52 Week Low
- PCVX $27.66
- COTY $3.67
- 52 Week High
- PCVX $121.06
- COTY $9.70
- Technical
- Relative Strength Index (RSI)
- PCVX 43.55
- COTY 42.62
- Support Level
- PCVX $31.47
- COTY $4.01
- Resistance Level
- PCVX $33.32
- COTY $4.53
- Average True Range (ATR)
- PCVX 1.23
- COTY 0.17
- MACD
- PCVX 0.12
- COTY 0.01
- Stochastic Oscillator
- PCVX 29.74
- COTY 56.40
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About COTY Coty Inc.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake as of June 2025.